Nanologica Publishes Annual Report for 2020
Nanologica hereby announces that the annual report for 2020 has been published. The report is available on the company’s website www.nanologica.com.
For further information, please contact:
Johanna Johansson, IR Nanologica
Ph: +46 72 211 21 90 or e-mail: [email protected]
About Nanologica AB (publ)
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface characteristics of silica particles. Through the two business areas, Drug Development and Chromatography, we are serving the industry by providing products for developing better and cheaper medicine for the benefits of patients. Nanologica operates from the headquarters in Södertälje, Sweden and Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.
